Bayforest Capital Ltd Has $37,000 Stock Holdings in HCA Healthcare, Inc. $HCA

Bayforest Capital Ltd decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 72.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 106 shares of the company’s stock after selling 280 shares during the quarter. Bayforest Capital Ltd’s holdings in HCA Healthcare were worth $37,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of HCA. Brighton Jones LLC purchased a new position in shares of HCA Healthcare during the fourth quarter valued at $1,021,000. ProShare Advisors LLC grew its holdings in shares of HCA Healthcare by 9.5% during the fourth quarter. ProShare Advisors LLC now owns 29,767 shares of the company’s stock valued at $8,935,000 after buying an additional 2,583 shares in the last quarter. Raiffeisen Bank International AG acquired a new stake in HCA Healthcare during the fourth quarter valued at $1,185,000. Rafferty Asset Management LLC boosted its position in HCA Healthcare by 9.8% during the fourth quarter. Rafferty Asset Management LLC now owns 20,689 shares of the company’s stock valued at $6,210,000 after purchasing an additional 1,843 shares during the last quarter. Finally, Silvercrest Asset Management Group LLC boosted its position in HCA Healthcare by 1,760.4% during the fourth quarter. Silvercrest Asset Management Group LLC now owns 32,464 shares of the company’s stock valued at $9,744,000 after purchasing an additional 30,719 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 1.30% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Wall Street Zen raised HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, July 5th. Cantor Fitzgerald reissued an “overweight” rating and set a $444.00 price objective on shares of HCA Healthcare in a research report on Tuesday, August 26th. Wells Fargo & Company reduced their price objective on HCA Healthcare from $385.00 to $375.00 and set an “equal weight” rating for the company in a research report on Thursday, August 14th. Morgan Stanley reduced their price target on HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a research report on Monday, July 28th. Finally, Royal Bank Of Canada reduced their price target on HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating for the company in a research report on Monday, July 28th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $403.17.

HCA Healthcare Price Performance

NYSE HCA opened at $405.54 on Friday. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $420.98. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98. The stock has a market capitalization of $94.89 billion, a PE ratio of 17.05, a P/E/G ratio of 1.27 and a beta of 1.41. The stock has a 50-day simple moving average of $382.88 and a 200 day simple moving average of $363.07.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The business had revenue of $18.61 billion during the quarter, compared to analysts’ expectations of $18.49 billion. During the same quarter in the previous year, the firm earned $5.50 EPS. The firm’s revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be paid a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare’s payout ratio is currently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.